CLASS II ONGOING Device recall · Reported 7 Aug 2024 · FDA Enforcement Report

BD Insyte Autoguard BC, Shielded IV Catheter recalled

Becton Dickinson Infusion Therapy Systems is recalling BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, distributed in Illinois. The recall was initiated on 26 Jun 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 4127714/ UDI-DI: 00382903825332
Quantity recalled26,400 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2458-2024
FDA event ID
94896
Classification
Class II
Status
Ongoing
Recall initiated
26 Jun 2024
FDA classified
31 Jul 2024
Reported
7 Aug 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

26 Jun 2024Recall initiated by company
31 Jul 2024Classified by FDA+35 days
7 Aug 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Catheters may contain a hole in the catheter tubing, which could result in leakage during the insertion process.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

BD Insyte Autoguard BC, Shielded IV Catheter with Blood Control Technology, REF: 382533, 20 GA x 1.00 in (1.1x25 mm) 63 mL/min, Rx Only. BD Insyte Autoguard BC Shielded IV Catheter is intended to be inserted into a patient's peripheral vascular system for short term use to sample blood, monitor blood pressure, or administer fluids.

Where it was distributed

US: IL OUS: N/A0

Illinois

Questions about this recall

Why was it recalled?

Catheters may contain a hole in the catheter tubing, which could result in leakage during the insertion process.

Which lots are affected?

Lot # 4127714/ UDI-DI: 00382903825332

Where was it sold?

US: IL OUS: N/A0

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson Infusion Therapy Systems

All 15

Other Heart & Vascular Devices recalls

All 6,220